CIK 0001763950 · Non-accelerated filer<br>Smaller reporting company
Lantern Pharma Inc.
Sign in to watch- Ticker
- LTRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- TX
- Entity type
- operating
- EIN
- 463973463
- Phone
- 972-277-1136
- Business address
- 1920 MCKINNEY AVENUE, 7TH FLOOR, DALLAS, TX, 75201
- Former names
- Lantern Pharma
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-04 | KEYSER D JEFFREY Director | Returned to the company · Stock Option (Right to Buy) | −3,200 | 0 | ||
| 2021-11-04 | KEYSER D JEFFREY Director | Grant or award · Stock Option (Right to Buy) | +3,200 | 3,200 | ||
| 2021-11-04 | Silberstein David S. Director | Returned to the company · Stock Option (Right to Buy) | −3,200 | 0 | ||
| 2021-11-04 | Silberstein David S. Director | Grant or award · Stock Option (Right to Buy) | +3,200 | 3,200 | ||
| 2021-11-04 | Kreis Leslie W. Director | Grant or award · Stock Option | +3,200 | 3,200 | ||
| 2021-11-04 | PRENDERGAST FRANKLYN G Director | Grant or award · Stock Option (Right to Buy) | +3,200 | 3,200 | ||
| 2021-11-04 | Silberstein David S. Director | Grant or award · Stock Option (Right to Buy) | +3,200 | 3,200 | ||
| 2021-11-04 | KEYSER D JEFFREY Director | Grant or award · Stock Option (Right to Buy) | +3,200 | 3,200 | ||
| 2021-11-04 | Chandru Vijay Director | Grant or award · Stock Option (Right to Buy) | +3,200 | 3,200 | ||
| 2021-10-29 | Bhatia Kishor G. Chief Scientific Officer | Returned to the company · Stock Option (Right to Buy) | −17,400 | 0 | ||
| 2021-10-29 | Bhatia Kishor G. Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +17,400 | 17,400 | ||
| 2021-10-29 | Margrave David R. Chief Financial Officer | Returned to the company · Stock Option (Right to Buy) | −26,100 | 0 | ||
| 2021-10-29 | Margrave David R. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +26,100 | 26,100 | ||
| 2021-10-29 | Bhatia Kishor G. Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +17,400 | 17,400 | ||
| 2021-10-29 | Margrave David R. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +26,100 | 26,100 | ||
| 2020-06-16 | Green Park & Golf Ventures II, LLC 10% owner | Conversion · Series A Preferred Stock, par value $0.01 | −75,688 | 0 | ||
| 2020-06-15 | Chandru Vijay Director | Returned to the company · Stock Option (Right to Buy) | −9,135 | 0 | ||
| 2020-06-15 | Chandru Vijay Director | Grant or award · Stock Option (Right to Buy) | +9,135 | 9,135 | ||
| 2020-06-15 | SHARMA PANNA President & CEO | Returned to the company · Stock Option (Right to Buy) | −76,628 | 0 | ||
| 2020-06-15 | SHARMA PANNA President & CEO | Grant or award · Stock Option (Right to Buy) | +76,628 | 76,628 |
Page 10 of 13 · 245 trades